Back to search

University of Crete (UOC)

In vitro μελέτη του ρόλου των αυξητικών παραγόντων στον πολλαπλασιασμό, μετανάστευση και διήθηση κυττάρων οστεοσαρκώματος

Abstract

dc:description

Backround: Osteosarcoma is the most common malignant bone tumor in childrenand adolescents, with frequency 4,4 / 1000000. Despite the significant increase in thesurvival rate of patients with osteosarcoma over the past decades, due to earlydiagnosis and the use of chemotherapy, the tumor cell pathophysiology remainslargely unknown and the presence of metastases continues to be a major negativeprognostic factor.Complex interactions between cancer cells, the extracellular matrix (ECM) and theadjacent normal cells play an important role in development and tumor progression.ECM composition affects important functions of normal and tumor cells, such asproliferation, adhesion, migration and differentiation. One of the main components ofthe extracellular matrix and cell membrane are proteoglycans (PGs), through whichtheir protein core or through their glycosaminoglycans (GAGs) chains are capableto interact with macromolecules of the extracellular matrix such as collagen, growthfactors, growth factor receptors and adhesion molecules , participating in this way tothe regulation of various cellular functions.Parathyroid hormone (PTH) as either an endogenous produced hormone or anadministered antiosteoporotic factor plays a key role in the physiology ofbone. However it remains largely unknown the importance of PTH action in primarybone tumors such as osteosarcomaAim: To study the effect of different parathyroid hormone peptides in the migration ofhuman osteosarcoma cell lines and to identify possible changes of the extracellularmatrix induced by PTH peptides that affect the migratory capacity of these cells. Moreover, the investigation of potential extracellular and intracellular signalingpathways that may regulate this specific cellular functionResults: we investigated whether the changes of HA metabolism induced by PTH (1–34) and PTH (7–84) peptides in moderately MG-63 and well-differentiated Saos 2osteosarcoma cell lines, are correlated to their migration capabilities. Our resultsdemonstrate that intermittent PTH (1–34) treatment significantly (P ≤ 0.01) supportedthe migration of MG-63 cells, increased their HA-synthase-2 (HAS2) expression (P≤0.001), and enhanced their high-molecular size HA deposition in the pericellularmatrix. Both increased endogenous HA production (P ≤ 0.01) and treatment withexogenous high-molecular weight HA (P ≤ 0.05) correlated to a significant increaseof MG-63 cell migration capacity. Transfection with siHAS2 showed that PTH (1–34), mainly through HAS2, enhanced HA and regulated MG-63 cell motility.Interestingly, continuous PTH (1–34) treatment stimulated both Saos 2 cell HAS2 (P≤0.001) and HAS1 (P ≤ 0.001) isoform expression inhibited their HYAL2 expression(P ≤ 0.001) and modestly (P ≤ 0.05) enhanced their migration. Therefore, the PTH (1–34) administration mode appears to distinctly modulate the migratory responses of theMG-63 moderately and Saos 2 well-differentiated osteosarcoma cell lines.Conclusively, the obtained data suggest that there is a regulatory effect of PTH (1–34), in an administration mode-dependent manner, on HA metabolism that is essentialfor osteosarcoma cell migration. Then we wanted to investigate the participation ofother potential pathways through which PTH(1-34) regulates the migratory capacityof osteosarcoma cells, through regulation of the composition of the extracellular andpericellular space. Thus, we investigated the possible participation of FGF-2 signalingin PTH(1–34)-dependent osteosarcoma cell migration. FGF-2 treatment of osteosarcoma cells resulted in a significant increase (P ≤ 0.01) in MG63 cellmigration, similar to that caused by PTH(1–34). mRNA expression analysis of cellstreated with PTH(1–34) showed a strong increase in FGF-2 transcript levels (P =0.0015). Interestingly, the addition of FGF-2 to MG63 cells led to significantdownregulation of small leucine-rich proteoglycan biglycan expression at both themRNA (P ≤ 0.0001) and protein (60%) levels. In order to examine the significance ofbiglycan on MG63 cell migration, transfection with short interfering RNA specific forbiglycan was performed, resulting in a significant increase (P ≤ 0.01) in the migrationcapacity of biglycan-deficient MG63 cells. In contrast, exogenous humanrecombinant biglycan strongly inhibited the migration of these cells (P ≤ 0.01).Finally, a direct correlation between PTH(1–34) action and biglycan expression wasestablished by the finding of a significant decrease (P ≤ 0.01) in biglycan transcriptlevels in PTH(1–34)-treated cells. To summarize, the present study demonstrates anovel cooperative mechanism of PTH(1–34) and FGF-2 action that results in specificalteration of the biglycan extracellular matrix content to regulate osteosarcoma cellmigration.. Taking into consideration the importance of TGFb in bone biology and theregulatory effect of the biglycan on TGFb action, in order to determine the necessityof TGF b for cell migration we created MG 63 biglycan-deficient osteosarcoma cells.We treated these cells with an antibody against TGFb and we found that whilebiglycan-deficient cells increased their migration capacity (P <0.01), biglycandeficientcells which were treated with the anti - TGFb1 antibody failed to increasetheir migration activity. These results show the importance of TGFb1 in migrationcapacity of MG63 cells .It has been shown that syndecan 4 plays an important role inthe biology of different tumor cells and that this role is achieved through complexFGFR / syndecan 4 interactions. We sought to determine the importance of syndecan4 in MG63 osteosarcoma cell migration. We proceeded to create MG 63 cellsdeficient in syndecan 4 (siSynd 4) in which we administered FGF 2 and found thatthey did not show the expected increase in their ability to migrate. Thereby shownthat syndecan 4 is an essential molecule in the mechanism in which the FGF -2achieves increased cell migration of MG 63 cells.Conclusions: With this study we identified two possible pathways through whichPTH (1-34) achieves its action on migration ability of osteosarcoma cells.1st Pathway: PTH (1-34) controlling the metabolism of hyaluronic acid (HA)increases the migratory ability of osteosarcoma cells.2nd Pathway: PTH (1-34) controlling the synthesis of biglycan through regulation ofFGF2 expression, manages to alter migration ability of osteosarcoma cells. Syndecan4is an essential component for the action of FGF2 in this pathway.

Degree

thesis:*
Grantor dc:publisher
University of Crete (UOC)
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Datsis, Georgios-Alexandros
  • Δάτσης, Γεώργιος-Αλέξανδρος

Subjects

dc:subject × 17

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/38713

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Datsis, Georgios-Alexandros; Δάτσης, Γεώργιος-Αλέξανδρος. In vitro μελέτη του ρόλου των αυξητικών παραγόντων στον πολλαπλασιασμό, μετανάστευση και διήθηση κυττάρων οστεοσαρκώματος. University of Crete (UOC), 2014. http://hdl.handle.net/10442/hedi/38713